Prexasertib dimesylate
- Product NamePrexasertib dimesylate
- CAS1234015-58-7
- CBNumberCB28202985
- MFC19H23N7O5S
- MW461.5
- MDL NumberMFCD32693943
- MOL File1234015-58-7.mol
- MSDS FileSDS
Chemical Properties
| form | Solid |
| color | Light yellow to yellow |
Prexasertib dimesylate Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| Biosynth JZB01558 | 10mg | $649 | Prexasertib (dimesylate) |
Buy |
| Biosynth JZB01558 | 25mg | $1038.5 | Prexasertib (dimesylate) |
Buy |
| Biosynth JZB01558 | 50mg | $1428 | Prexasertib (dimesylate) |
Buy |
| Biosynth JZB01558 | 100mg | $2207 | Prexasertib (dimesylate) |
Buy |
| ChemScene CS-0130202 | 5mg | $119 | Prexasertib (dimesylate) 98.90% |
Buy |
Prexasertib dimesylate Chemical Properties,Usage,Production
Uses
Prexasertib dimesylate (LY2606368 dimesylate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib dimesylate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib dimesylate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib dimesylate shows potent anti-tumor activity[1][2].in vivo
Prexasertib dimesylate (LY2606368 dimesylate; 1-10 mg/kg; SC; twice daily for 3 days, rest 4 days; for three cycles) causes growth inhibition in tumor xenografts[1].
Prexasertib dimesylate (15 mg/kg; SC) causes CHK1 inhibition in the blood and the phosphorylation of both H2AX (S139) and RPA2 (S4/S8)[1].
| Animal Model: | Female CD-1 nu-/nu- mice (26-28 g) with Calu-6 cells[1] |
| Dosage: | 1, 3.3, or 10 mg/kg |
| Administration: | SC; twice daily for 3 days, rest 4 days; for three cycles |
| Result: | Caused statistically significant tumor growth inhibition (up to 72.3%). |
| Animal Model: | Female CD-1 nu-/nu- mice (26-28 g) with Calu-6 cells[1] |
| Dosage: | 15 mg/kg (Pharmacokinetic Analysis) |
| Administration: | SC (200 μL) |
| Result: | CHK1 was 7 ng/mL at 12 hours and 3 ng/mL by 24 hours in plasma exposures. Phosphorylation of both H2AX (S139) and RPA2 (S4/S8) was detectable at 4 hours, showing the rapid occurrence of DNA damage. |
IC 50
Chk1: 0.9 nM (Ki); Chk1: <1 nM (IC50); Chk2: 8 nM (IC50)References
[1] King C, et al. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Mol Cancer Ther. 2015 Sep;14(9):2004-1 DOI:10.1158/1535-7163.MCT-14-1037[2] Yin Y, et al. Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer. Am J Cancer Res. 2017 Mar 1;7(3):473-483. PMID:28401005
Preparation Products And Raw materials
Prexasertib dimesylate Suppliers
Global(13)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 1-631-485-4226; 16314854226 |
info@bocsci.com | United States | 9920 | 65 | |
| 18916372613 | yanzihan@shyuanye.com | China | 87240 | 60 | |
| 021-31433387 15618786686 |
sales@rechemscience.com | China | 2969 | 58 | |
| 400-9205774 400-920-5774 |
sales@glpbio.cn | China | 6705 | 58 | |
| 18818260767 | sales@chemegen.com | China | 11123 | 58 | |
| 15821661757 | 226174156@qq.com | China | 476 | 58 | |
| 021-65675885 18964387627 |
customer_service@efebio.com | China | 11963 | 58 | |
| 6206333 13167063860 |
anhua.mao@aladdin-e.com | China | 49511 | 58 | |
| 18024082417 | market@ubiochem.com | China | 9831 | 58 | |
| 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
1234015-58-7, Prexasertib dimesylateRelated Search
- 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride
- Prexasertib dimesylate
- 2-Pyrazinecarbonitrile, 5-[[5-(2-hydroxy-6-methoxyphenyl)-1H-pyrazol-3-yl]amino]-, dihydrochloride
- Prexasertib mesylate
- 2-Pyrazinecarbonitrile, 5-[[5-[2-[(trans-3-aminocyclobutyl)oxy]-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-
1of2
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine